WHITTIER TRUST CO - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
WHITTIER TRUST CO ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$0200.0%0.00%
Q2 2020$0200.0%0.00%
Q1 2020$0200.0%0.00%
Q4 2019$0
-100.0%
20
-98.4%
0.00%
Q3 2019$3,0001,280
+6300.0%
0.00%
Q2 2019$0200.0%0.00%
Q1 2019$0200.0%0.00%
Q4 2018$0200.0%0.00%
Q3 2018$0200.0%0.00%
Q2 2018$0200.0%0.00%
Q1 2018$0200.0%0.00%
Q4 2017$0200.0%0.00%
Q3 2017$0200.0%0.00%
Q2 2017$0200.0%0.00%
Q1 2017$0200.0%0.00%
Q4 2016$0200.0%0.00%
Q3 2016$0200.0%0.00%
Q2 2016$0200.0%0.00%
Q1 2016$0200.0%0.00%
Q4 2015$0200.0%0.00%
Q3 2015$0200.0%0.00%
Q2 2015$0200.0%0.00%
Q1 2015$0200.0%0.00%
Q4 2014$0200.0%0.00%
Q3 2014$0200.0%0.00%
Q2 2014$0200.0%0.00%
Q1 2014$0200.0%0.00%
Q4 2013$0200.0%0.00%
Q3 2013$0200.0%0.00%
Q2 2013$0200.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2016
NameSharesValueWeighting ↓
SMH CAPITAL ADVISORS INC 81,713$176,0000.39%
BRANDES INVESTMENT PARTNERS, LP 5,465,156$11,805,0000.30%
Crestline Management, LP 875,000$1,890,0000.30%
West Family Investments, Inc. 539,450$1,165,0000.29%
WEBER ALAN W 200,000$432,000,0000.19%
Zebra Capital Management LLC 73,910$160,0000.18%
RBF Capital, LLC 569,323$1,230,0000.14%
Leap Investments LP 69,496$150,0000.08%
Connor, Clark & Lunn Investment Management Ltd. 4,387,038$9,476,0000.06%
CHICAGO EQUITY PARTNERS LLC 519,315$1,122,0000.05%
View complete list of PDL BIOPHARMA INC shareholders